Advertisement

Journal of Molecular Medicine

, Volume 84, Issue 12, pp 1015–1022 | Cite as

Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer

  • Matthias Treiber
  • Hans-Ulrich Schulz
  • Olfert Landt
  • Joost PH Drenth
  • Carlo Castellani
  • Francisco X. Real
  • Nejat Akar
  • Rudolf W. Ammann
  • Mario Bargetzi
  • Eesh Bhatia
  • Andrew Glenn Demaine
  • Cinzia Battagia
  • Andrew Kingsnorth
  • Derek O’Reilly
  • Kaspar Truninger
  • Monika Koudova
  • Julius Spicak
  • Milos Cerny
  • Hans-Jürgen Menzel
  • Pedro Moral
  • Pier Franco Pignatti
  • Maria Grazia Romanelli
  • Olga Rickards
  • Gian Franco De Stefano
  • Narcis Octavian Zarnescu
  • Gourdas Choudhuri
  • Sadiq S. Sikora
  • Jan B. M. J. Jansen
  • Frank Ulrich Weiss
  • Matthias Pietschmann
  • Niels Teich
  • Thomas M. Gress
  • Johann Ockenga
  • Hartmut Schmidt
  • Andreas Kage
  • Juliane Halangk
  • Jonas Rosendahl
  • David Alexander Groneberg
  • Renate Nickel
  • Heiko WittEmail author
Original Article

Abstract

Keratin 8 (KRT8) is one of the major intermediate filament proteins expressed in single-layered epithelia of the gastrointestinal tract. Transgenic mice over-expressing human KRT8 display pancreatic mononuclear infiltration, interstitial fibrosis and dysplasia of acinar cells resulting in exocrine pancreatic insufficiency. These experimental data are in accordance with a recent report describing an association between KRT8 variations and chronic pancreatitis. This prompted us to investigate KRT8 polymorphisms in patients with pancreatic disorders. The KRT8 Y54H and G62C polymorphisms were assessed in a cohort of patients with acute and chronic pancreatitis of various aetiologies or pancreatic cancer originating from Austria (n=16), the Czech Republic (n=90), Germany (n=1698), Great Britain (n=36), India (n=60), Italy (n=143), the Netherlands (n=128), Romania (n=3), Spain (n=133), and Switzerland (n=129). We also studied 4,234 control subjects from these countries and 1,492 control subjects originating from Benin, Cameroon, Ethiopia, Ecuador, and Turkey. Polymorphisms were analysed by melting curve analysis with fluorescence resonance energy transfer probes. The frequency of G62C did not differ between patients with acute or chronic pancreatitis, pancreatic adenocarcinoma and control individuals. The frequency of G62C varied in European populations from 0.4 to 3.8%, showing a northwest to southeast decline. The Y54H alteration was not detected in any of the 2,436 patients. Only 3/4,580 (0.07%) European, Turkish and Indian control subjects were heterozygous for Y54H in contrast to 34/951 (3.6%) control subjects of African descent. Our data suggest that the KRT8 alterations, Y54H and G62C, do not predispose patients to the development of pancreatitis or pancreatic cancer.

Keywords

Keratin 8 Acute pancreatitis Chronic pancreatitis Pancreatic carcinoma 

Notes

Acknowledgements

The authors thank Michael Becker, Thomas Berg, Jana Bernardova, Claudia Güldner, Werner Luck, Seraphina Serole, Bertram Wiedenmann, Ulrike Witt (Berlin), Markus Lerch, Peter Simon (Greifswald), Helmut Friess, Beat Künzli (Heidelberg), Volker Keim (Leipzig), Walter Halangk, Christiane Jechorek (Magdeburg), Wolfgang Böck (Ulm), Milan Macek Jr. (Prague), Mariette Verlaan (Nijmegen), Giovanni Destro-Bisol (Rome), Roberta Galavotti (Verona) for collecting clinical data, support and/or excellent technical assistance. The initial experiments of this study were supported by the Deutsche Forschungsgemeinschaft (Wi 2036/1-1). The study was supported by the Sonnenfeld-Stiftung (Berlin, Germany), by the Dutch foundation of Digestive Diseases (MLDS WS00-21), and by VZFNM 00064203(6112) to Milan Macek. Dr. Joost P. H. Drenth is a recipient of a NWO-VIDI grant.

Supplementary material

References

  1. 1.
    Ammann RW, Bühler H, Münch R, Freiburghaus AW, Siegenthaler W (1987) Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas 2:368–377PubMedCrossRefGoogle Scholar
  2. 2.
    Whitcomb DC, Gorry MC, Preston RA et al (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141–145PubMedCrossRefGoogle Scholar
  3. 3.
    Witt H, Luck W, Becker M (1999) A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 117:7–10PubMedCrossRefGoogle Scholar
  4. 4.
    Witt H, Luck W, Hennies HC et al (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216PubMedCrossRefGoogle Scholar
  5. 5.
    Drenth JP, te Morsche R, Jansen JB (2002) Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50:687–692PubMedCrossRefGoogle Scholar
  6. 6.
    Sharer N, Schwarz M, Malone G et al (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645–652PubMedCrossRefGoogle Scholar
  7. 7.
    Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658PubMedCrossRefGoogle Scholar
  8. 8.
    Castellani C, Gomez Lira M, Frulloni L et al (2001) Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis. Hum Mutat 18:166PubMedCrossRefGoogle Scholar
  9. 9.
    Fuchs E, Weber K (1994) Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345–382PubMedGoogle Scholar
  10. 10.
    Schüssler MH, Skoudy A, Ramaekers F, Real FX (1992) Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 140:559–568PubMedGoogle Scholar
  11. 11.
    Casanova ML, Bravo A, Ramirez A et al (1999) Exocrine pancreatic disorders in transgenic mice expressing human keratin 8. J Clin Invest 103:1587–1595PubMedCrossRefGoogle Scholar
  12. 12.
    Ku NO, Gish R, Wright TL, Omary MB (2001) Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med 344:1580–1587PubMedCrossRefGoogle Scholar
  13. 13.
    Ku NO, Darling JM, Krams SM et al (2003) Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci USA 100:6063–6068PubMedCrossRefGoogle Scholar
  14. 14.
    Cavestro GM, Frulloni L, Nouvenne A et al (2003) Association of keratin 8 gene mutation with chronic pancreatitis. Dig Liver Dis 35:416–420PubMedCrossRefGoogle Scholar
  15. 15.
    Bradley EL 3rd (1993) A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 128:586–590PubMedGoogle Scholar
  16. 16.
    Porta M, Costafreda S, Malats N et al (2000) For the PANKRAS II Study Group. Hospital discharge diagnosis in biliopancreatic pathology: validity analysis and recommendations for epidemiologic studies. Eur J Epidemiol 16:533–541PubMedCrossRefGoogle Scholar
  17. 17.
    Büning C, Halangk J, Dignass A et al (2004) Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Dig Liver Dis 36:388–391PubMedCrossRefGoogle Scholar
  18. 18.
    Antonarakis SE (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1–3PubMedCrossRefGoogle Scholar
  19. 19.
    Schneider A, Lamb J, Barmada MM, Cuneo A, Money ME, Whitcomb DC (2005) Keratin 8 mutations are not associated with familial, sporadic and alcoholic pancreatitis in a population from the United States. Pancreatology 6:103–108PubMedCrossRefGoogle Scholar
  20. 20.
    Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24PubMedCrossRefGoogle Scholar
  21. 21.
    Baribault H, Price J, Miyai K, Oshima RG (1993) Mid-gestational lethality in mice lacking keratin 8. Genes Dev 7:1191–1202PubMedGoogle Scholar
  22. 22.
    Baribault H, Penner J, Iozzo RV, Wilson-Heiner M (1994) Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 8:2964–2973PubMedGoogle Scholar
  23. 23.
    Toivola DM, Baribault H, Magin T, Michie SA, Omary MB (2000) Simple epithelial keratins are dispensable for cytoprotection in two pancreatitis models. Am J Physiol Gastrointest Liver Physiol 279:G1343–G1354PubMedGoogle Scholar
  24. 24.
    Blessing M, Rüther U, Franke WW (1993) Ectopic synthesis of epidermal cytokeratins in pancreatic islet cells of transgenic mice interferes with cytoskeletal order and insulin production. J Cell Biol 120:743–755PubMedCrossRefGoogle Scholar
  25. 25.
    Halangk J, Berg T, Puhl G et al (2004) Keratin 8 Y54H and G62C mutations are not associated with liver disease. J Med Genet 41:e92PubMedCrossRefGoogle Scholar
  26. 26.
    Hesse M, Berg T, Wiedenmann B et al (2004) A frequent keratin 8 p. L227L polymorphism, but no point mutations in keratin 8 and 18 genes, in patients with various liver disorders. J Med Genet 41:e42PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Matthias Treiber
    • 1
    • 2
  • Hans-Ulrich Schulz
  • Olfert Landt
  • Joost PH Drenth
  • Carlo Castellani
  • Francisco X. Real
  • Nejat Akar
  • Rudolf W. Ammann
  • Mario Bargetzi
  • Eesh Bhatia
  • Andrew Glenn Demaine
  • Cinzia Battagia
  • Andrew Kingsnorth
  • Derek O’Reilly
  • Kaspar Truninger
  • Monika Koudova
  • Julius Spicak
  • Milos Cerny
  • Hans-Jürgen Menzel
  • Pedro Moral
  • Pier Franco Pignatti
  • Maria Grazia Romanelli
  • Olga Rickards
  • Gian Franco De Stefano
  • Narcis Octavian Zarnescu
  • Gourdas Choudhuri
  • Sadiq S. Sikora
  • Jan B. M. J. Jansen
  • Frank Ulrich Weiss
  • Matthias Pietschmann
  • Niels Teich
  • Thomas M. Gress
  • Johann Ockenga
  • Hartmut Schmidt
  • Andreas Kage
  • Juliane Halangk
  • Jonas Rosendahl
  • David Alexander Groneberg
  • Renate Nickel
  • Heiko Witt
    • 1
    • 2
    Email author
  1. 1.Department of Hepatology and Gastroenterology, Charité, Campus Virchow-KlinikumUniversitätsmedizin BerlinBerlinGermany
  2. 2.Department of Pediatrics, Charité, Campus Virchow-KlinikumUniversitätsmedizin BerlinBerlinGermany

Personalised recommendations